The kisspeptin (KiSS-1)/GPR54 system in cancer biology

Cancer Treatment Reviews

Volumn 34, Issue 8, 2008, Pages 682-692

  Makri, Angeliki ^a   Pissimissis, Nikolaos ^a   Lembessis, Peter ^a   Polychronakos, Constantine ^b   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer; GPR54 receptor; KiSS 1 gene; Kisspeptins

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; KISSPEPTIN; MESSENGER RNA;

AUTOCRINE EFFECT; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CHORIOCARCINOMA; DIGESTIVE SYSTEM CANCER; ENDOCRINE FUNCTION; ENDOMETRIUM CANCER; ESOPHAGUS CARCINOMA; EVIDENCE BASED PRACTICE; GENE EXPRESSION PROFILING; HUMAN; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; MELANOMA; METASTASIS; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PARACRINE SIGNALING; PHEOCHROMOCYTOMA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; THYROID CANCER; TROPHOBLAST; TROPHOBLASTIC TUMOR; UVEA MELANOMA;

ANIMALS; APOPTOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; NEOPLASM METASTASIS; NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; SENSITIVITY AND SPECIFICITY;

EID: 56249104751     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2008.05.007     Document Type: Review

References (105)

1. Koutsilieris M., Dimopoulos M.A., Doillon C., Sourla A., Reyes-Moreno C., and Choki I. The molecular concept of prostate cancer. Cancer J 9 (1996) 89-94
2. Koutsilieris M., Laroche B., Thabet M., and Fradet Y. The assessment of disease aggressivity in stage D2 prostate cancer patients (review). Anticancer Res 10 (1990) 333-336
3. Bogdanos J., Karamanolakis D., Tenta R., et al. Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton. Endocr Relat Cancer 10 (2003) 279-289
4. Koutsilieris M., Tzanela M., and Dimopoulos T. Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report. Prostate 38 (1999) 313-316
5. Lee J.H., Miele M.E., Hicks D.J., et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88 (1996) 1731-1737
6. Seminara S.B., Messager S., Chatzidaki E.E., et al. The GPR54 gene as a regulator of puberty. N Engl J Med 349 (2003) 1614-1627
7. Teles M.G., Bianco S.D., Brito V.N., et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358 (2008) 709-715
8. Luan X., Yu H., Wei X., et al. GPR54 polymorphisms in Chinese girls with central precocious puberty. Neuroendocrinology 86 (2007) 77-83
9. Luan X., Zhou Y., Wang W., et al. Association study of the polymorphisms in the KISS1 gene with central precocious puberty in Chinese girls. Eur J Endocrinol 157 (2007) 113-118
10. Gottsch M.L., Cunningham M.J., Smith J.T., et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 145 (2004) 4073-4077
11. Shahab M., Mastronardi C., Seminara S.B., Crowley W.F., Ojeda S.R., and Plant T.M. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA 102 (2005) 2129-2134
12. Adachi S., Yamada S., Takatsu Y., et al. Involvement of anteroventral periventricular metastin/kisspeptin neurons in estrogen positive feedback action on luteinizing hormone release in female rats. J Reprod Dev 53 (2007) 367-378
13. Maeda K., Adachi S., Inoue K., Ohkura S., and Tsukamura H. Metastin/kisspeptin and control of estrous cycle in rats. Rev Endocr Metab Disord 8 (2007) 21-29
14. Roa J., and Tena-Sempere M. KiSS-1 system and reproduction: comparative aspects and roles in the control of female gonadotropic axis in mammals. Gen Comp Endocrinol 153 (2007) 132-140
15. Revel F.G., Ansel L., Klosen P., et al. Kisspeptin: a key link to seasonal breeding. Rev Endocr Metab Disord 8 (2007) 57-65
16. Blache D., Zhang S., and Martin G.B. Dynamic and integrative aspects of the regulation of reproduction by metabolic status in male sheep. Reprod Nutr Dev 46 (2006) 379-390
17. Fernandez-Fernandez R., Martini A.C., Navarro V.M., et al. Novel signals for the integration of energy balance and reproduction. Mol Cell Endocrinol 254-255 (2006) 127-132
18. Tena-Sempere M. KiSS-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 83 (2006) 275-281
19. Bilban M., Ghaffari-Tabrizi N., Hintermann E., et al. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 117 (2004) 1319-1328
20. Hiden U., Bilban M., Knofler M., and Desoye G. Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord 8 (2007) 31-39
21. Horikoshi Y., Matsumoto H., Takatsu Y., et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 88 (2003) 914-919
22. Dhillo W.S., Murphy K.G., and Bloom S.R. The neuroendocrine physiology of kisspeptin in the human. Rev Endocr Metab Disord 8 (2007) 41-46
23. Janneau J.L., Maldonado-Estrada J., Tachdjian G., et al. Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 87 (2002) 5336-5339
24. Farina A., Sekizawa A., Purwosunu Y., et al. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenatal Diag 26 (2006) 1115-1120
25. Gaytan M., Castellano J.M., Roa J., Sanchez-Criado J.E., Tena-Sempere M., and Gaytan F. Expression of KiSS-1 in rat oviduct: possible involvement in prevention of ectopic implantation?. Cell Tissue Res 329 (2007) 571-579
26. Qiao C., Wang C.H., Shang T., and Lin Q.D. Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates. Zhonghua Fu Chan Ke Za Zhi 40 (2005) 585-590
27. Panidis D., Rousso D., Koliakos G., et al. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil Steril 85 (2006) 1778-1783
28. Mead E.J., Maguire J.J., Kuc R.E., and Davenport A.P. Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. Endocrinology 148 (2007) 140-147
29. Hauge-Evans A.C., Richardson C.C., Milne H.M., Christie M.R., Persaud S.J., and Jones P.M. A role for kisspeptin in islet function. Diabetologia 49 (2006) 2131-2135
30. Castellano J.M., Navarro V.M., Fernandez-Fernandez R., et al. Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats. Diabetes 55 (2006) 2602-2610
31. Rometo A.M., Krajewski S.J., Voytko M.L., and Rance N.E. Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab 92 (2007) 2744-2750
32. Miele M.E., Jewett M.D., Goldberg S.F., et al. A human melanoma metastasis-suppressor locus maps to 6q16.3-q23. Int J Cancer 86 (2000) 524-528
33. Murphy K.G. Kisspeptins: regulators of metastasis and the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 17 (2005) 519-525
34. Mitchell D.C., Abdelrahim M., Weng J., et al. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1. J Biol Chem 281 (2006) 51-58
35. Dockray G.J. The expanding family of -RFamide peptides and their effects on feeding behaviour. Exp Physiol 89 (2004) 229-235
36. Ohtaki T., Shintani Y., Honda S., et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411 (2001) 613-617
37. Muir A.I., Chamberlain L., Elshourbagy N.A., et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276 (2001) 28969-28975
38. Kotani M., Detheux M., Vandenbogaerde A., et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276 (2001) 34631-34636
39. Lee D.K., Nguyen T., O'Neill G.P., et al. Discovery of a receptor related to the galanin receptors. FEBS Lett 446 (1999) 103-107
40. Cerrato F., and Seminara S.B. Human genetics of GPR54. Rev Endocr Metab Disord 8 (2007) 47-55
41. Masui T., Doi R., Mori T., et al. Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315 (2004) 85-92
42. Navenot J.M., Wang Z., Chopin M., Fujii N., and Peiper S.C. Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res 65 (2005) 10450-10456
43. Becker J.A., Mirjolet J.F., Bernard J., et al. Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors. Biochem Biophys Res Commun 326 (2005) 677-686
44. Stathatos N., Bourdeau I., Espinosa A.V., et al. KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab 90 (2005) 5432-5440
45. Hori A., Honda S., Asada M., et al. Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 286 (2001) 958-963
46. Harms J.F., Welch D.R., and Miele M.E. KISS1 metastasis suppression and emergent pathways. Clin Exp Metastas 20 (2003) 11-18
47. Nash K.T., Phadke P.A., Navenot J.M., et al. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 99 (2007) 309-321
48. Martin T.A., Watkins G., and Jiang W.G. KiSS-1 expression in human breast cancer. Clin Exp Metastas 22 (2005) 503-511
49. Goldberg S.F., Miele M.E., Hatta N., et al. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 63 (2003) 432-440
50. Shirasaki F., Takata M., Hatta N., and Takehara K. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61 (2001) 7422-7425
51. Mitchell D.C., Stafford L.J., Li D., Bar-Eli M., and Liu M. Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene 26 (2007) 1739-1747
52. Hesling C., D'Incan M., Mansard S., et al. In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. Brit J Dermatol 150 (2004) 761-767
53. Lee J.H., and Welch D.R. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57 (1997) 2384-2387
54. Marot D., Bieche I., Aumas C., et al. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr Relat Cancer 14 (2007) 691-702
55. Kostadima L., Pentheroudakis G., and Pavlidis N. The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer. Anticancer Res 27 (2007) 2499-2504
56. Stark A.M., Tongers K., Maass N., Mehdorn H.M., and Held-Feindt J. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131 (2005) 191-198
57. Dhar D.K., Naora H., Kubota H., et al. Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111 (2004) 868-872
58. Yao H.L., Yang Z.L., Li Y.G., and Liu G.W. In situ hybridization study on the expression of Kiss-1 and KAI-1 metastasis suppressor genes in gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 10 (2007) 274-277
59. Yu G., Chen Y., and Ni C. Reduced protein expression of metastasis-related genes (nm23, KiSS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Path 88 (2007) 175-183
60. Ikeguchi M., Yamaguchi K., and Kaibara N. Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res 10 (2004) 1379-1383
61. Ikeguchi M., Hirooka Y., and Kaibara N. Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol 129 (2003) 531-535
62. Schmid K., Wang X., Haitel A., et al. KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch 450 (2007) 143-149
63. Hou Y.K., Wang Y., Cong W.M., and Wu M.C. Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma. Ai Zheng 26 (2007) 591-595
64. Liang S., and Yang Z.L. Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32 (2007) 109-113
65. Ringel M.D., Hardy E., Bernet V.J., et al. Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab 87 (2002) 2399
66. Hata K., Dhar D.K., Watanabe Y., Nakai H., and Hoshiai H. Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer 43 (2007) 1452-1459
67. Gao G., Liu L., Zou X., and Chen W. Expression of KiSS-1, matrix metalloproteinase-9, nuclear fator-kappaBp56 in ovarian tumor. Zhongua Fu Chan Ke Za Zhi 42 (2007) 34-38
68. Zhang S.L., Yu Y., Jiang T., Lin B., and Gao H. Expression and significance of KiSS-1 and its receptor GPR54 mRNA in epithelial ovarian cancer. Zhonghua Fu Chan Ke Za Zhi 40 (2005) 689-692
69. Jiang Y., Berk M., Singh L.S., et al. KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastas 22 (2005) 369-376
70. Jiang T., Zhang S.L., Lin B., Meng L.R., and Gao H. Expression and clinical significance of KISS-1 and GPR54 mRNA in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi 27 (2005) 229-231
71. Dhillo W.S., Savage P., and Murphy K.G. Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab 291 (2006) E878-E884
72. Ohta S., Lai E.W., Pang A.L., et al. Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer 114 (2005) 139-143
73. Sanchez-Carbayo M., Capodieci P., and Cordon-Cardo C. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 162 (2003) 609-617
74. Martins C.M., Fernandes B.F., Antecka E., et al. Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Eye (2008)
75. Sanchez-Carbayo M., Belbin T.J., Scotlandi K., et al. Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes. Lab Invest 83 (2003) 507-517
76. Zohrabian V.M., Nandu H., Gulati N., et al. Gene expression profiling of metastatic brain cancer. Oncol Rep 18 (2007) 321-328
77. Nomura H., Sato H., Seiki M., Mai M., and Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55 (1995) 3263-3266
78. Yan C., Wang H., and Boyd D.D. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. J Biol Chem 276 (2001) 1164-1172
79. Takino T., Koshikawa N., Miyamori H., et al. Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. Oncogene 22 (2003) 4617-4626
80. Mead E.J., Maguire J.J., Kuc R.E., and Davenport A.P. Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Brit J Pharmacol 151 (2007) 1143-1153
81. Boulanger J., Reyes-Moreno C., and Koutsilieris M. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG-63 human osteosarcoma cells. Int J Cancer 61 (1995) 692-697
82. Dimitriadou V., and Koutsilieris M. Mast cell-tumor cell interactions: for or against tumour growth and metastasis?. Anticancer Res 17 (1997) 1541-1549
83. Janvier R., Sourla A., Koutsilieris M., and Doillon C.J. Stromal fibroblasts are required for PC-3 human prostate cancer cells to produce capillary-like formation of endothelial cells in a three-dimensional co-culture system. Anticancer Res 17 (1997) 1551-1557
84. Koutsilieris M. Pathophysiology of uterine leiomyomas. Biochem Cell Biol 70 (1992) 273-278
85. Koutsilieris M. Osteoblastic metastasis in advanced prostate cancer. Anticancer Res 13 (1993) 443-449
86. Koutsilieris M. Skeletal metastases in advanced prostate cancer: cell biology and therapy. Crit Rev Oncol Hematol 18 (1995) 51-64
87. Koutsilieris M., Allaire-Michaud L., Fortier M., and Lemay A. Mitogen(s) for endometrial-like cells can be detected in human peritoneal fluid. Fertil Steril 56 (1991) 888-893
88. Koutsilieris M., Frenette G., Lazure C., Lehoux J.G., Govindan M.V., and Polychronakos C. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 13 (1993) 481-486
89. Koutsilieris M., Mitsiades C., and Sourla A. Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. Mol Med 6 (2000) 251-267
90. Koutsilieris M., Niklinski W., Frenette G., and Lemay A. Heparin-sepharose binding growth factors in peritoneal fluid of women with endometriosis. Fertil Steril 59 (1993) 93-97
91. Koutsilieris M., and Polychronakos C. Proteinolytic activity against IGF-binding proteins involved in the paracrine interactions between prostate adenocarcinoma cells and osteoblasts. Anticancer Res 12 (1992) 905-910
92. Koutsilieris M., Rabbani S.A., Bennett H.P., and Goltzman D. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. J Clin Invest 80 (1987) 941-946
93. Koutsilieris M., Sourla A., Pelletier G., and Doillon C.J. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer. J Bone Miner Res 9 (1994) 1823-1832
94. Mitsiades C.S., Mitsiades N., and Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 4 (2004) 235-256
95. Polychronakos C., Janthly U., Lehoux J.G., and Koutsilieris M. Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved. Prostate 19 (1991) 313-321
96. Reyes-Moreno C., Frenette G., Boulanger J., Lavergne E., Govindan M.V., and Koutsilieris M. Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells. Prostate 26 (1995) 260-269
97. Sourla A., Doillon C., and Koutsilieris M. Three-dimensional type I collagen gel system containing MG-63 osteoblasts-like cells as a model for studying local bone reaction caused by metastatic cancer cells. Anticancer Res 16 (1996) 2773-2780
98. Sourla A., Polychronakos C., and Zeng W. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas. Cancer J 9 (1996) 89-94
99. Tsigkos S., Koutsilieris M., and Papapetropoulos A. Angiopoietins in angiogenesis and beyond. Expert Opin Inv Drug 12 (2003) 933-941
100. Zucker S., Pei D., Cao J., and Lopez-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 54 (2003) 1-74
101. Iizuka M., Abe M., Shiiba K., Sasaki I., and Sato Y. Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis. J Vasc Res 41 (2004) 334-344
102. Minami T., Horiuchi K., Miura M., et al. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279 (2004) 50537-50554
103. Li D., Mitchell D., Luo J., et al. Estrogen regulates KiSS1 gene expression through estrogen receptor alpha and SP protein complexes. Endocrinology 148 (2007) 4821-4828
104. Taylor P.M., Woodfield R.J., Hodgkin M.N., et al. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A(2) and 5-lipoxygenase catalyzed pathway. Oncogene 21 (2002) 5765-5772
105. Dhillo W.S., Chaudhri O.B., Patterson M., et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 90 (2005) 6609-6615